Skip to content

VITRO BIOPHARMA, INC.: 10-Q filed 2016-01-22

What VITRO BIOPHARMA, INC. reported in its quarterly report filed 2016-01-22 (fiscal Q2 2015): 27 published measures, 74 facts as tagged in accession 0001376474-16-000531.

This filing

Form
10-Q (quarterly report)
Filed
2016-01-22
Fiscal period
fiscal Q2 2015
Accession
0001376474-16-000531 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All VITRO BIOPHARMA, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2015-04-30105,170USD
At 2014-10-31105,582USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2015-04-302,389,439USD
At 2014-10-312,265,588USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2015-04-30-2,284,269USD
At 2014-10-31-2,160,006USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2015-04-305,734USD
At 2014-10-312,767USD
At 2014-04-301,464USD
At 2013-10-312,197USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2015-02-01 to 2015-04-30-75,393USD89
2014-11-01 to 2015-04-30-124,263USD181
2013-11-01 to 2015-04-30-124,263USD546
2014-02-01 to 2014-04-30-64,078USD89
2013-11-01 to 2014-04-30-118,986USD181
2012-11-01 to 2013-10-31-246,527USD365

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2014-11-01 to 2015-04-30-69,272USD181
2013-11-01 to 2014-04-30-71,134USD181

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2015-02-01 to 2015-04-3020,400USD89
2014-11-01 to 2015-04-3034,884USD181
2014-02-01 to 2014-04-3027,611USD89
2013-11-01 to 2014-04-3052,279USD181

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2014-11-01 to 2015-04-3077,627USD181
2013-11-01 to 2014-04-3071,061USD181

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2014-11-01 to 2015-04-30-5,388USD181
2013-11-01 to 2014-04-30-660USD181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2015-04-30-7,737,087USD
At 2014-10-31-7,612,824USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2015-04-3038,620USD
At 2014-10-3141,851USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2013-11-01 to 2014-04-305,000USD181

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2015-02-01 to 2015-04-30-53,683USD89
2014-11-01 to 2015-04-30-81,952USD181
2014-02-01 to 2014-04-30-45,233USD89
2013-11-01 to 2014-04-30-82,491USD181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2015-04-3048,643USD
At 2014-10-3146,725USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2015-02-01 to 2015-04-30-21,710USD89
2014-11-01 to 2015-04-30-42,311USD181
2014-02-01 to 2014-04-30-18,845USD89
2013-11-01 to 2014-04-30-36,495USD181

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2015-04-302,389,439USD
At 2014-10-312,265,588USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2015-04-3064,141USD
At 2014-10-3147,976USD

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2015-04-3029,976USD
At 2014-10-3122,330USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2015-02-01 to 2015-04-3015,789USD89
2014-11-01 to 2015-04-3026,058USD181
2014-02-01 to 2014-04-3013,379USD89
2013-11-01 to 2014-04-3018,740USD181

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2015-02-01 to 2015-04-3017,187USD89
2014-11-01 to 2015-04-3030,083USD181
2014-02-01 to 2014-04-3022,181USD89
2013-11-01 to 2014-04-3048,246USD181

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2015-02-01 to 2015-04-3056,896USD89
2014-11-01 to 2015-04-3086,753USD181
2014-02-01 to 2014-04-3050,663USD89
2013-11-01 to 2014-04-3086,524USD181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2015-04-3019,971,822shares
At 2014-10-3119,971,822shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2015-04-305,432,847USD
At 2014-10-315,432,847USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2015-04-30-2,284,269USD
At 2013-10-31-2,160,006USD
At 2012-10-31-1,933,479USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2015-04-30127,679USD
At 2014-10-31121,560USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2015-04-3013,181USD
At 2014-10-3114,780USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2015-02-01 to 2015-04-30-75,393USD89
2014-11-01 to 2015-04-30-124,263USD181
2014-02-01 to 2014-04-30-64,078USD89
2013-11-01 to 2014-04-30-118,986USD181

Inspect the source

Entity
VITRO BIOPHARMA, INC. / CIK 0000793171
Captured
2026-09-21T17:17:03.076Z
SEC response SHA-256
e4a45888e3fd56bf245fee78b2235f6f8d9c94b7a357b46c64ff1e0e8b6cac32

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000793171.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))